Type 2 diabetes and health care costs in Latin America: Exploring the need for greater preventive medicine

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Arredondo, Armando ^a,b  

^a Division of Biological Risks and Occupational Health   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Chronic diseases; Diabetes; Economic burden; Epidemiological transition; Latin American countries; Universal coverage

Indexed keywords

ARTICLE; CHRONIC DISEASE; DISABILITY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE PRACTICE; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; MEDICAL CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION; PREMATURE MORTALITY; PREVENTIVE MEDICINE; SOUTH AND CENTRAL AMERICA; DIABETES MELLITUS, TYPE 2; ECONOMICS; HEALTH SERVICE; STATISTICS AND NUMERICAL DATA;

DIABETES MELLITUS, TYPE 2; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; LATIN AMERICA;

EID: 84910092814     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-014-0136-z     Document Type: Article

References (18)

1. Shaw J, Sicree R, Zimment P. Global estimates of the prevalence of diabetes for 2110 and 2030. Diabetes Res Clin Pract 2010, 87:4-14. 10.1016/j.diabres.2009.10.007, 19896746.
2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study. Lancet 2012, 380:2095-2117. 10.1016/S0140-6736(12)61728-0, 23245604.
3. Frenk J, Bobadilla JL, Stern C, Lozano R. The epidemiological transition in Latin America. Bol Oficina Sanit Panam 1991, 111:485-496. 1838685.
4. Arredondo A, Zúñiga A. Economic consequences of epidemiological changes in diabetes in middle income countries: the Mexican case. Diabetes Care 2004, 27:104-109. 10.2337/diacare.27.1.104, 14693974.
5. International Diabetes Federation: Direct Cost to the Health Care Sector. Diabetes Health Economics. Brussels, Belgium; 2010..
6. Amos AF, McCarty D, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 2010, 5:S51-S85.
7. Arredondo A, Icaza E. Financial requirements for diabetes in Latin America: evidence and implications for the health system and for patients in Mexico. Diabetologia 2009, 52:1693-1695. 10.1007/s00125-009-1417-5, 19504083.
8. Barcelo A, Aedo C, Rajpathak S, Robles S. The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ 2003, 81:19-27. 12640472.
9. Zhang P, Zhang X, Brown J, Vistisen D, Sicree R. Global healthcare expenditure on diabetes for 2010 and 2030. Diabet Res 2010, 87:293-301.
10. Bank W: Universal Healthcare on the Rise in Latin America. Working Paper. Washington D.C; 2013..
11. Giedion U. Designing and implementing explicit health benefits packages in Latin America. Report of the Roundtable Discussion on Universal Health Coverage 2013, 6-7. Policy Wisdom, Washington D.C.
12. Cortez R, Romero D. Increasing Utilization of Health Care Services among the Uninsured Population: the Plan Nacer Program. Working Paper No. 74956 2013, World Bank Series, Buenos Aires.
13. Quentin T. Poverty and Policy in Latin America and the Caribbean, Technical Paper 2013, World Bank, Washington DC.
14. Cercone J. Asociación público-privada para la atención a la salud. El desafío de la reforma en salud. Foro de Europa y América sobre las Reformas del Sector Salud. Nota Técnica 2014, Banco Mundial, Santiago de Chile.
15. Arredondo A, Reyes G. Health disparities from economic burden of diabetes in middle-income countries: evidence from México. PloS One 2013, 8:e68443. 10.1371/journal.pone.0068443, 23874629.
16. Avezum A, Braga J, Santos I, Marín J, Piegas L. Cardiovascular disease in South America: current status and opportunities for prevention. Heart 2009, 95:1475-1482. 10.1136/hrt.2008.156331, 19224906.
17. Arredondo A, Orozco E, Aviles R: Evidence on equity, governance and financing after health care reform in Mexico: lessons for Latin American countries.Jou Saúde e Sociedade, in press..
18. Nava G. Adherencia al Tratamiento y Deserción de Pacientes con Diabetes, Informe Técnico Parcial 2012, Universidad Autonoma de Hidalgo, México.